Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewGENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle t...
GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle that will invest in early stage projects from healthcare research
-
Press releaseSanifit, Ysios Capital, Splice Bio and MOA foodtech recognised at first AseBio – PwC Award...
The ceremony to award these 6 prizes to Spanish biotechnology took place at AseBio Investor Day 2022, which brought together over 260 participants from all over Europe Sanifit has received three
-
NewSanifit, Ysios Capital, Splice Bio and MOA foodtech recognised at first AseBio – PwC Award...
The ceremony to award these 6 prizes to Spanish biotechnology took place at AseBio Investor Day 2022, which brought together over 260 participants from all over Europe
-
Press releaseSpanish biotechnology hits new record, attracting over €180 million in private investment ...
Private investment in the biotech industry up 20% from 2020. The figures were announced at AseBio Investor Day 2022, which brought together over 50 investors from all over Europe and more than 260
-
NewSpanish biotechnology hits new record, attracting over €180 million in private investment ...
Private investment in the biotech industry up 20% from 2020. The figures were announced at AseBio Investor Day 2022, which brought together over 50 investors from all over Europe and more than 260
-
NewThe Spanish start-up Real Deal Milk opens a funding round of 2 million euros
The Spanish start-up Real Deal Milk (RDM), based in the Barcelona Science park, has opened a €2 million funding round that will go towards boosting R&D activity and expanding its lab, which is located
-
EventARAB HEALTH Dubái 2023 – Convocatoria ICEX
ICEX España Exportación e Inversiones organiza un Pabellón de España en la feria ARAB HEALTH 2023. La inscripción al Pabellón España está abierta hasta el 29 de abril.
-
New“In this business, you never stop being a scientist”
Participants and sponsors of AseBio Investor Day 2022, just two days away, give us some tips for setting up a biotech company from academia
-
EventBiotech Communications 101 Seminar - Consilium & AseBio Investor Day
In the framework of the AseBio Investor Day 2022 that we are holding next Thursday 28th April, our partners have the opportunity to get in touch with one of the most important strategic health comm
-
NewPharmaBoardoom points out VIVEbiotech as one of the ten Spanish Biotechs to watch in 2022
PharmaBoardroom, a leading British media specialized in the health sector, has published an article in which it highlights VIVEbiotech as one of the ten Spanish biotechs to follow in 2022.
-
NewNostrum Biodiscovery names Majeed Hosseiney as Chief Executive Officer
In his new role, Hosseiney will be responsible for the oversight and continued growth of NBD's Global Operations
-
NewIf you’re an entrepreneur or researcher and wish to develop your biotechnology Project, th...
The facilities of the Biotechnology Business Incubator (Bioincubator), located in Castilla y León at the Boecillo Technology Park in Valladolid, Spain, are fully prepared for the start of activity
-
NewThe 2050 Challenge: A Shift In Food Production. LINNA®, Natural Intelligence Powered By Ar...
Aiming to protect human health and the environment, Kimitec, has been researching and developing for the last 15 years natural solutions capable of replacing synthetic chemicals in food production
-
NewDIVERSA launches DIVTECH kits, a new solution for the cellular delivery of molecules, and ...
After just three months since the incorporation of DIVERSA Technologies, the company has already struck some deals that will bolster its commercial activities within Europe
-
NewBiofish 3000 yake: the only method on the market for the objective determination of the de...
BIOLAN launches a new analytical solution that allows to quantitatively classify the degree of YAKE in tuna, without the need to defrost and generate damage in the piece, and digitally monitor its
-
NewZeClinics partners with the Institut de la Vision to test in zebrafish the most cutting-ed...
ZeClinics has recently started a new collaboration with the Institut de la Vision, led by Filippo del Bene, to test in zebrafish the most cutting-edge genetic modification technologies
-
NewA perfect case study of CRO – Pharma successful alliance
ZeClinics and Dompé Farmaceutici started this collaboration a few years ago, in an effort to validate the use of zebrafish to reliably model human retinopathies and, most importantly, to test
-
-
NewAlgenex obtains GMP certification from Spanish Drug Agency for the manufacture of active P...
GMP is the highest quality seal that certifies that the Spanish biotechnology company complies with the Good Manufacturing Practices for the manufacture of pharmaceutical products in the European
-
NewHighlight Therapeutics announces follow-up results from Phase 2b study of BO-112 + anti-PD...
BO-112 demonstrates potential as new and highly effective second line therapy for melanoma
-
NewAlmirall announces research collaborations on dermatological diseases with the University ...
Almirall recently announced collaboration agreements with the University of Michigan to accelerate the understanding of the factors that trigger hidradenitis suppurativa